UDENYCA

Active substance: pegfilgrastim

INJECTION, SOLUTION · PEGFILGRASTIM 6 mg/.6mL

United StatesActive

Marketing holder: Accord BioPharma, Inc.

Verified 2026-10-09 · openFDA NDC

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
EU 25	Cavoley pegfilgrastim EMEA/H/C/005008 Stada Arzneimittel AG Cavoley pegfilgrastim EMEA/H/C/004342 STADA Arzneimittel AG Cavoley pegfilgrastim EMEA/H/C/006937 CuraTeQ Biologics s.r.o Cegfila (previously Pegfilgrastim Mundipharma) pegfilgrastim EMEA/H/C/005312 Mundipharma Corporation (Ireland) Limited Dyrupeg pegfilgrastim EMEA/H/C/006407 CuraTeQ Biologics (Malta) Limited All products in this country (25)

Country

Products

EU 25

Cavoley
pegfilgrastim
EMEA/H/C/005008
Stada Arzneimittel AG
Cavoley
pegfilgrastim
EMEA/H/C/004342
STADA Arzneimittel AG
Cavoley
pegfilgrastim
EMEA/H/C/006937
CuraTeQ Biologics s.r.o
Cegfila (previously Pegfilgrastim Mundipharma)
pegfilgrastim
EMEA/H/C/005312
Mundipharma Corporation (Ireland) Limited
Dyrupeg
pegfilgrastim
EMEA/H/C/006407
CuraTeQ Biologics (Malta) Limited

Import and control

United Statesprescription only
Source: openFDA NDC · record 01a1208c-2cc4-7405-93df-3fcf885057a8,01a1208c-3bd8-7203-8ce7-829e5a242329,01a1208d-a08d-7608-8b47-ceddfdb64392,01a1208e-af77-7893-8d83-f10a539fc002,01a1208e-d68f-76c8-b808-731f81c60b8a;count=16 · valid from 2026-10-09 · verified 2026-10-09